Advertisement

Ersatz von Blut und Blutkomponenten

  • W. Sibrowski
  • P. Krakowitzky
Chapter
  • 98 Downloads

Zusammenfassung

Die Gabe von Blut und Blutprodukten bedarf einer strengen Indikationstellung. Es ist zu berücksichtigen, dass das verschreibungspflichtige Arzneimittel „Blut“ aus verschiedenen Anteilen besteht, deren Gabe zu vielfältigen Nebenwirkungen beim Patienten führen kann.

Bei der Transfusion von Blut und Blutkomponenten sind verschiedene Regelwerke zu beachten, deren Kenntnis von jedem Arzt verlangt wird:
  • Transfusionsgesetz

  • Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie)

  • Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten der Bundesärztekammer

Literatur

  1. Arbeitskreis Blut: Parvovirus B 19. Stellungnahme S3 vom 2. 12. 1998. Abrufbar unter: www.rki.de/GESUND/AKBLUT/BLUT.HTMGoogle Scholar
  2. Bowden RA, Meyers JD (1990) Prophylaxis of cytomegalovirus infection. Semin Hematol 2(Suppl 1):17–21Google Scholar
  3. Bowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L et al. (1995) A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of tranfsuion-associated CMV infection after marrow transplant. Blood 86:3598–3603PubMedGoogle Scholar
  4. Bux J, Cassens U, Duchscherer M, Eichler H, Haas C, Haustein B, Moog R, Wiesneth M (2001) Preliminary results of the multicenter study „treatment of blood donors with recombinat G-CSF for granulocyte apheresis“. Inus Ther Transfus Med 28 (Sonderheft 1):18Google Scholar
  5. Bux J, Mueller-Eckhardt C (1993) Leitlinien für die Substitutionstherapie mit Thrombozyten. Dtsch Med Wochenschr 118:1367–1370PubMedGoogle Scholar
  6. Bux J, Hoch J, Bindl L, Müller A, Mueller-Eckhardt C (1994) Transfusionsassoziierte akute Lungeninsuffizienz. Diagnosesicherung durch den Nachweis granulozytärer Antikörper. Dtsch Med Wochenschr 119:19–24PubMedGoogle Scholar
  7. Caspari G, Alpen U, Greinacher A (2001) Transfusion to the wrong patient likely to be most important tranfusion risk. Infusionsther Transfusionsmed 28 (Sonderheft 1):V 29.1Google Scholar
  8. Consensus Conference (1985) Fresh Frozen Plasma, Indications and Risks. JAMA 253:551–553Google Scholar
  9. Consensus Conference (1987) Platelet transfusion therapy. JAMA 257:1777–1780Google Scholar
  10. Consensus Statement on red cell transfusion (1994) Br J Anaesth 73:857–859Google Scholar
  11. Davenport RD, Kunkel SL (1994) Cytokine roles in hemolytic and nonhemolytic transfusion reactions. Transfusion Med Rev 8:157–168Google Scholar
  12. Grassi M, Mammarella A, Sagliaschi G, Granati L, Musca A, Traditi F, Pezzella M (2001) Persistent hepatitis G virus (HGV) infection in chronic hemodialysis patients and non-B, non-C chronic hepatitis. Clin Chem Lab Med 39:956–960CrossRefPubMedGoogle Scholar
  13. Greinacher A, Lubenow N, Hinz P, Ekkernkamp A (2003) Heparin induzierte Thrombozytopenie. Dtsch Ärztebl 100:A2220–2229Google Scholar
  14. Halasz R, Weiland O, Sallberg M (2001) GB virus C/hepatitis G virus. Scand J Infect Dis 33:572–580PubMedGoogle Scholar
  15. Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Folsch UR, Schmidt WE (2002) Prevalence of and risk factors for hepatitis G (HGV) infection in haemodialysis patients: a multicentre study. Nephrol Dial Transplant 17:271–275PubMedGoogle Scholar
  16. Hoffmeister KM, Felbinger TW, Falet H, Denis CV, Bergmeier W, Mayadas TN, von Andrian UH, Wagner DD, Stossel TP, Hartwig JH (2003) The clearance mechanism of chilled blood platelets. Cell 112:87–97CrossRefPubMedGoogle Scholar
  17. Jacobs RJ, Palavecino E, Yomtovian R (2001) Don’t bug me: The problem of bacterial contamination of blood components — challenges and solutions. Transfusion 41; 1331–1334CrossRefPubMedGoogle Scholar
  18. Linden JV, Kaplan HS (1994) Transfusion errors: Causes and effects. Transfus Med Rev 8:169–183PubMedGoogle Scholar
  19. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363:417–421CrossRefPubMedGoogle Scholar
  20. Mollison PL, Engelfried CP, Contreras M (eds) (1997) Blood transfusion in clinical medicine, 10th ed. Blackwell, OxfordGoogle Scholar
  21. Mueller-Eckhardt C (Hrsg) (1996) Transfusionsmedizin, 2. Aufl. Springer, Berlin Heidelberg New YorkGoogle Scholar
  22. Ness P, Braine H, King K, Barrasso Ch, Kickler T, Fuller A, Blades N (2001) Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 41:857–861PubMedGoogle Scholar
  23. Nichols WG, Price TH, Gooley T, Corey L, Boeckh M (2003) Transfusion-transmitted cytomegalovirus infection after receipt of leuko-reduced blood products. Blood 101:4195–4200PubMedGoogle Scholar
  24. Petz LD, Swisher SN, Kleinmann S, Spence RK, Straus RG (eds) (1996) Clinical practice of transfusion medicine, 3rd edn. Churchill Livingstone, New York Edinburgh LondonGoogle Scholar
  25. Price TH, Bowden RA, Boeckh M, Bux J, Nelson K, Liles WC, Dale DC (2000) Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood 95:3302–3309PubMedGoogle Scholar
  26. Robert-Koch-Institut (2001) Bericht der Arbeitsgruppe „Gesamtstrategie Blutversorgung angesichts vCJK“ August 2001 Abrufbar unter: http://www.rki.de/PRESSE/PD/PD2001/PD01_25.HTMGoogle Scholar
  27. Sachs UJ, Bux J (2003) TRALI after the transfusion of cross-match-positive granulocytes. Transfusion 43:1683–1686CrossRefPubMedGoogle Scholar
  28. Salama A, Mueller-Eckhardt C (1984) Delayed hemolytic transfusion reactions. Transfusion 24:188–190CrossRefPubMedGoogle Scholar
  29. van Prooijen HC, Visser JJ, van Oostendorp WR, de Gast GC, Verdonck LF (1994) Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters. Br J Haematol 87:144–147PubMedGoogle Scholar
  30. Vengelen-Tyler V (ed.) (1999) Technical manual, 13th edn. American Association of Blood Banks, BethesdaGoogle Scholar
  31. Xu JZ, Yang ZG, Le MZ, Wang MR, He CL, Sui YH (2001) A study on pathogenicity of hepatitis G virus. World J Gastroenterol 7:547–550PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag 2005

Authors and Affiliations

  • W. Sibrowski
  • P. Krakowitzky

There are no affiliations available

Personalised recommendations